Calliditas Therapeutics AB (publ) (CALT) Earnings
|
Expand Research on CALT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +3.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/11/24 | Q324 | N/A | $0.13 | N/A | N/A | $55.46M | N/A | N/A | N/A | ||
| 8/13/24 | Q224 | N/A | -$0.08 | N/A | N/A | $43.46M | N/A | N/A | N/A | ||
| 5/23/24 | Q124 | N/A | -$0.19 | N/A | N/A | $35.16M | N/A | N/A | N/A | ||
| 5/7/24 | Q124 | N/A | -$0.16 | N/A | N/A | $36.45M | N/A | N/A | N/A | ||
| 2/21/24 | Q423 | N/A | -$0.15 | N/A | N/A | $34.97M | N/A | N/A | N/A | ||
| 11/16/23 | Q323 | N/A | -$0.13 | N/A | N/A | $29.64M | N/A | N/A | N/A | ||
| 8/17/23 | Q223 | N/A | -$0.25 | N/A | N/A | $27.06M | N/A | N/A | N/A | ||
| 5/16/23 | Q123 | N/A | -$0.35 | N/A | N/A | $22.22M | N/A | N/A | N/A |
